Prelude Therapeutics
(NASDAQ:PRLD)
$6.64
0.31[4.90%]
Last update: 11:32AM
Day Range6.22 - 6.6452 Wk Range3.87 - 13.4Open / Close6.48 / -Float / Outstanding6.8M / 47.8M
Vol / Avg.20.3K / 95.3KMkt Cap317.6MP/E-50d Avg. Price7.06
Div / Yield-Payout Ratio-Total Float6.8MEPS-0.58

Prelude Therapeutics Stock (NASDAQ:PRLD), Quotes and News Summary

Prelude Therapeutics Stock (NASDAQ: PRLD)

Day Range6.22 - 6.6452 Wk Range3.87 - 13.4Open / Close6.48 / -Float / Outstanding6.8M / 47.8M
Vol / Avg.20.3K / 95.3KMkt Cap317.6MP/E-50d Avg. Price7.06
Div / Yield-Payout Ratio-Total Float6.8MEPS-0.58
Sector: Health Care.Industry: Biotechnology
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-11
REV
Q2 2022Est.ActualSurprise
EPS-0.650-0.580 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Prelude Therapeutics Questions & Answers

Q
How do I buy Prelude Therapeutics (PRLD) stock?
A

You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Prelude Therapeutics's (PRLD) competitors?
Q
What is the target price for Prelude Therapeutics (PRLD) stock?
A

The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by Morgan Stanley on Friday, September 9, 2022. The analyst firm set a price target for 11.00 expecting PRLD to rise to within 12 months (a possible 65.66% upside). 9 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Prelude Therapeutics (PRLD)?
A

The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $6.64 last updated Today at September 28, 2022, 3:32 PM UTC.

Q
Does Prelude Therapeutics (PRLD) pay a dividend?
A

There are no upcoming dividends for Prelude Therapeutics.

Q
When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?
A

Prelude Therapeutics’s Q3 earnings are confirmed for Friday, November 11, 2022.

Q
Is Prelude Therapeutics (PRLD) going to split?
A

There is no upcoming split for Prelude Therapeutics.

Q
What sector and industry does Prelude Therapeutics (PRLD) operate in?
A

Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.